COVID-19: Antidepressant reduces risk of hospitalization and death
A clinical trial has found that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, significantly reduces the chances of hospitalization …
Home ยป
Does hydroxychloroquine cut COVID-19 mortality? Expert urges caution
The antimalaria drug hydroxychloroquine has generated significant controversy. A new study suggests that if it is given early, it can …
First human trial of SARS-CoV-2 vaccine: Initial results in
Researchers from China report the initial findings of the first human trial for a potential vaccine against SARS-CoV-2, the new …